Ashwat Nagarajan

1.3k citations
6 papers · 847 · 1 hit paper · h-index 4

Impact in

  • Immunology top 10%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction
    • Immune cells in cancer
    • T-cell and B-cell Immunology
  • Oncology top 10%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research

Papers in

    • Reproductive System and Pregnancy 1
    • interferon and immune responses 1
    • Cancer Genomics and Diagnostics 1

Ashwat Nagarajan

5 papers receiving 831 citations

Ashwat Nagarajan's Hit Papers

Immune checkpoint therapy—current perspectives and future directions 2023 · 793 citations
7930+1+2Years since publication250500750

Peers

Ashwat Nagarajan
Comparison fields: 5 of 72
  • Immunology 330
  • Oncology 358
  • Cancer Research 60
  • Biological Psychiatry 7
  • Molecular Biology 187
Replace Luna Minute with:
Luna Minute Spain
Paula Dobosz Poland
Alessia Zoso United States
Susanna Nguy United States
Anna Karolina Kozłowska Poland
Ihor Arkhypov Germany
Marine Bruand Switzerland
Shamim Ahmad United States
Margaux Vienne France
Jens H. W. Pahl Germany
Ashwat Nagarajan relative to Luna Minute Spain Luna Minute's profile →
Citations per field
00.5×2×3×3.9×
Luna Minute · 1×
Citations per year

Countries citing papers authored by Ashwat Nagarajan

Since Specialization
Citations

This map shows the geographic impact of Ashwat Nagarajan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashwat Nagarajan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashwat Nagarajan more than expected).

Fields of papers citing papers by Ashwat Nagarajan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashwat Nagarajan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashwat Nagarajan. The network helps show where Ashwat Nagarajan may publish in the future.

Co-authors

The 25 scholars most cited alongside Ashwat Nagarajan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ashwat Nagarajan Line = papers co-authored together Ashwat Nagarajan links everyone, so they are left out of the graph.

All Works

6 of 6 papers shown
#Work
1
Immune checkpoint therapy—current perspectives and future directions
Hit paper breakdown →
2023793
2 201234
3 202412
4 20257
5 20251
6 20250

About Ashwat Nagarajan

Ashwat Nagarajan is a scholar working on Immunology, Cancer Research, Oncology, Biotechnology and Hematology, having authored 6 papers that have together received 847 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (2 papers), Acute Myeloid Leukemia Research (1 paper), Sphingolipid Metabolism and Signaling (1 paper), Cancer Research and Treatments (1 paper), Cancer Genomics and Diagnostics (1 paper), Reproductive System and Pregnancy (1 paper), interferon and immune responses (1 paper) and RNA regulation and disease (1 paper). The work is most often cited by research in Immunology (330 citations), Oncology (358 citations), Cancer Research (60 citations), Biological Psychiatry (7 citations) and Molecular Biology (187 citations). Ashwat Nagarajan has collaborated with scholars based in United States, Israel and India. Frequent co-authors include Swetha Anandhan, Padmanee Sharma, Shelley M. Herbrich, Gayathri Anandappa, Moran Amit, Deblina Raychaudhuri, Shajedul Islam, Candice C. Poon, Bilal Ahmed Siddiqui and Jielin Liu. Their work appears in journals such as Cellular Signalling, Nature Communications, Cancer Cell, Cell Reports and Science Advances.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact